NSDBG LIMITED
Opportunity 71/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-02-28 | 2024-02-29 |
|---|---|---|
| Total assets | £60.1k | £92.5k |
| Current assets | £54.0k | £28.1k |
| Cash | £51.2k | £24.3k |
| Debtors | £2.9k | £3.8k |
| Net assets | £9.5k | £26.0k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (13 events)Click to expand
- 2025-11-26📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-02-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-11-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-02-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-02-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-12-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-11-05📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-06-21📄change-corporate-secretary-company-with-change-dateofficers · CH04
- 2018-06-21📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2018-02-26🏢Company incorporatedAs NSDBG LIMITED
- 2018-02-26➕INFINITY SECRETARIES LIMITED appointedcorporate-secretary
- 2018-02-26➕YOVCHEV, Mihael appointeddirector
- 2018-02-26📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 8 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Marieta Georgieva Individual · British · DOB 07/1991 · age 35 | 25–50% | — | 25-50% shares | 26/02/2018 |
Mihael Yovchev Individual · Bulgarian · DOB 04/1990 · age 36 | 25–50% | — | 25-50% shares | 26/02/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · AB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| ABERDEEN OSTEOPATHY CLINIC LIMITED→ SC381838 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| AGE REVERSAL THERAPIES LTD→ SC723766 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| AJASUE SERVICES LTD→ SC645316 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AJF PSYCHOTHERAPY LTD→ SC841025 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ALGON MEDICAL LIMITED→ SC379990 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| AN STOKES PHYSIO LTD→ SC730537 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ANGUS MACLEOD LTD→ SC843843 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ASSURED OCCUPATIONAL HEALTH LIMITED→ SC496266 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| AUTISM AND NEURODIVERSITY NORTH SCOTLAND LIMITED→ SC186663 · est 1998 · no financials extracted | — | — | — | — | 27y | — | — |
| AUTISM SPECIFIC CONSULTANCY SERVICES SCOTLAND LTD→ SC717145 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AVK DENTAL CARE LIMITED→ SC458451 · est 2013 · no financials extracted | — | — | — | — | 12y | — | — |
| BANCHORY CHIROPODY PRACTICE LTD→ SC426815 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.